Skip navigation

Senate Extends Pharma Grants Probe

“Receiving a letter from the United States Senate Finance Committee is a frightening experience,” said a CME professional from a major pharmaceutical company during a hot-topics session at the Alliance for CME annual conference. From the comments other attendees made, it appears that many CME professionals, whether on the industry or provider side, agree that the government's focus on funding is definitely something to worry about.

Register to view the full article

Register for and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.